期刊文献+

扩张型心肌病37例临床分析 被引量:1

在线阅读 下载PDF
导出
摘要 目的:探讨扩张型心肌病的有效治疗方法。方法:对37例患者给予ACEI,β阻滞剂、利尿剂、醛固酮拮抗剂、正性肌力药治疗,并分析其疗效。结果:37例中,好转出院35例,自动出院1例,死亡1例(电解质紊乱)。住院(12.8±5.6)天。结论:联合用药可显著改善症状,提高生存率。
机构地区 陕西中医学院
出处 《现代医药卫生》 2008年第15期2273-2274,共2页 Journal of Modern Medicine & Health
  • 相关文献

参考文献8

  • 1程宽,王齐兵,李高平,舒先红,陈瑞珍,杨英珍,秦胜梅,葛均波,陈灏珠.扩张型心肌病280例临床分析[J].临床心血管病杂志,2006,22(7):393-396. 被引量:27
  • 2Richardson P, MckennaW, BristowW,et al.Reportof the 1995 Word Organization/InternationalSociety and Federation of Cardiol-ogyTask Force on the definition and classification of cardiomyopa-thies[J]. Circulation, 1996,93(5):841.
  • 3全国心肌炎心肌病学术研讨会纪要[J].中华心血管病杂志,1999,27(6):408-412. 被引量:137
  • 4Bristow MR. Beta-adrenergic receptor blockade in chronic heart failure[J].Circulation,2000,101(5): 558.
  • 5CIBIS- Ⅱ Investigation and Committee.The cardiac insufficiency Bi2soprolo Study Ⅱ (CIB IS2 Ⅱ ):a randomised trial[J].Lancet, 1999, 353(6):9.
  • 6MER IT2HF Study Group.Effect of metop rolo CR/XL in chronic heart failure:Metop rolo CR/XL randiomised intervention trial in congestive heart failure(MER IT2HF)[J].Lancet, 1999,353(6):2001.
  • 7The Carvedilol Prospective Randomize Cumulative Survival Study Group.Effect of carvedilol on survival in severe chronic heart failure [J].N Engl J Med,2001,344(6):1651.
  • 8The DigitalisInvestigation Group.The effect of digoxin on mortality and morbidity in patients with heart failure{J].NEngl J Med, 1997, 336(6):525.

二级参考文献17

  • 1徐军,马文珠,王敬良,杜福昌.家族性扩张型心肌病调查及其遗传特点分析[J].中华心血管病杂志,1994,22(4):263-264. 被引量:25
  • 2巫相宏,谢秀梅,马国添,孙国举.家族性扩张型心肌病的临床特点和家谱分析[J].临床心血管病杂志,2006,22(1):30-32. 被引量:3
  • 3祝家庆,王燕妮,杨鼎颐,王文茂.特发性扩张型心肌病心力衰竭148例预后因素分析[J].西安医科大学学报,1996,17(4):487-490. 被引量:6
  • 4RICHARDSON P, McKENNA W, BRISTOW W, et al. Report of the 1995 Word Organization/International Society and Federation of Cardiology Task Foree on the definition and elassifieation of eardiomyopathies[J]. Circulation, 1996, 93:841-842.
  • 5DI LENARDA A, SECOLI G, PERKAN A , et al.Changing mortality in dilated eardiomyopathy[J]. Br Heart J,1994 ,72:S46-S51.
  • 6GAVAZZI A, De MARIA R, PORCU M, et al. Dilated cardiomyopathy: a new natural history? The experience of the Italian multicenter cardiomyopathy study (SPIC) [J]. G Ital Cardiol, 1995, 25:1109-1125.
  • 7DI LENARDA A, PINAMONTI B, MESTRONI L ,et al. The natural history of dilated cardiomyopathy:a review of the heart muscle disease registry of trieste[J]. Ital Heart J Suppl,2004,5:253-266.
  • 8GRIMM W, MAISCH B. Sudden cardiac death in dilated cardiomyopathy -therapeutic options[J]. Herz,2002,27:750-759.
  • 9BURKETT E L, HERSHBERGER R E. Clinical and genetic issues in familial dilated cardiomyopathy[J]. J Am Coll Cardio, 2005 , 45: 969-981.
  • 10CRISPELL K A, WRAY A, NI H, et al. Clinical profiles of four large pedigrees with familial dilated cardiomyopathy: preliminary recommendations for clinical practice[J]. J Am Coll Cardiol, 1999,34:837-847.

共引文献160

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部